Yury Morozov | Neuroscience | Innovative Research Award

Published on by Cell Biologist

Innovative Research Award

Yury Morozov
Yale School of Medicine, Department of Neuroscience, United States

Yury Morozov
Affiliation Yale School of Medicine, Department of Neuroscience
Country United States
Scopus ID 12243546400
Documents 47
Citations 3,747
h-index 28
Subject Area Neuroscience
Event World Cell Biologist Awards
ORCID 0000-0002-3679-6819

Yury Morozov is a researcher affiliated with the Department of Neuroscience at Yale School of Medicine in the United States. His academic profile is associated with neuroscience research and scholarly contributions reflected in indexed publication and citation records. According to the supplied bibliometric information, his research portfolio comprises 47 documents, 3,747 citations, and an h-index of 28. His profile is presented in connection with the Innovative Research Award of the World Cell Biologist Awards, recognizing research contributions and their relevance to the broader scientific community. [1]

Abstract

This academic recognition profile presents the research background and bibliometric information of Yury Morozov, affiliated with the Department of Neuroscience at Yale School of Medicine, United States. His scholarly record includes 47 indexed documents, 3,747 citations, and an h-index of 28, according to the information supplied for this profile. The article outlines his institutional affiliation, research domain, publication record, scholarly visibility, and relevance to the Innovative Research Award presented by the World Cell Biologist Awards. The profile provides an overview of research recognition within the wider context of neuroscience and biomedical investigation. [1] [2]

Keywords

Yury Morozov; Innovative Research Award; Neuroscience; Yale School of Medicine; Department of Neuroscience; Biomedical Research; Scientific Publications; Research Impact; Citation Analysis; Academic Recognition; World Cell Biologist Awards.

Introduction

Neuroscience is an interdisciplinary scientific field concerned with the structure, function, development, and organization of the nervous system. It integrates molecular biology, cellular biology, physiology, genetics, computational methods, and clinical investigation to understand neural processes and their implications for health and disease. Research in this area contributes to the development of scientific knowledge concerning brain function, neural communication, and neurological conditions. [1] [3]

Research Profile

Yury Morozov’s academic affiliation is the Department of Neuroscience at Yale School of Medicine. His stated subject area is neuroscience, a broad discipline encompassing the study of nervous system organization, neural development, cellular processes, and functional mechanisms. Institutional affiliation and indexed author information provide a framework for identifying scholarly contributions and examining research activity across publications. [2] [3]

Research Contributions

Research contributions in neuroscience can span multiple levels of biological organization, from molecular and cellular mechanisms to neural circuits and integrated nervous system functions. The field depends on experimental approaches, quantitative analysis, and interdisciplinary collaboration to investigate complex biological questions. [2]

Publications

The supplied Scopus profile information reports 47 documents associated with Yury Morozov. Publication records provide an important basis for evaluating research activity, scholarly collaboration, and the dissemination of scientific findings. The Scopus author profile is the principal reference point for examining the indexed publication list and associated citation information. [5]

Research Impact

Research impact can be assessed through several complementary indicators, including publication output, citation activity, scholarly collaboration, methodological contributions, and the influence of research findings on subsequent investigations. Citation metrics provide quantitative evidence of how frequently indexed publications are cited within scholarly literature, but they should not be treated as a complete measure of scientific quality or societal impact.

The supplied profile reports 3,747 citations and an h-index of 28 across 47 documents. The h-index represents a relationship between publication output and citation frequency, indicating that at least 28 publications have received 28 or more citations, provided the figures correspond to the same database snapshot and author record. These indicators offer a quantitative overview of scholarly visibility in the indexed literature. [4]

Award Suitability

The Innovative Research Award of the World Cell Biologist Awards is associated with the recognition of research activity, scientific contributions, and innovation across relevant biomedical and life science disciplines. Neuroscience represents an important research domain within biomedical science, with connections to cellular mechanisms, molecular processes, neural function, and neurological investigation.

Yury Morozov’s supplied academic profile identifies his institutional affiliation, subject area, publication output, and citation indicators. These details provide relevant background for an academic recognition profile. A complete award assessment should additionally examine the originality of specific research findings, documented contributions, publication quality, and the candidate’s demonstrated influence within the relevant scientific field. [4]

Conclusion

Yury Morozov’s academic profile reflects an association with the Department of Neuroscience at Yale School of Medicine in the United States. The supplied bibliometric information records 47 documents, 3,747 citations, and an h-index of 28 in the subject area of neuroscience. These indicators provide a quantitative overview of his indexed scholarly activity and form part of the academic information presented in connection with the Innovative Research Award of the World Cell Biologist Awards. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Yury Morozov, Author ID 12243546400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12243546400
  2. K Pattabiraman, SK Muchnik, N Kaur, YM Morozov, et al. (2021). Hominini-specific regulation of CBLN2 increases prefrontal spinogenesis.
    https://www.nature.com/articles/s41586-021-03952-y
  3. SN Leslie, M Wang, YM Morozov, et al. (2021). Age‐related calcium dysregulation linked with tau pathology and impaired cognition in non‐human primates.
    https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12325
  4. D Franjic, M Skarica, S Ma, YM Morozov, et al. (2022). Transcriptomic taxonomy and neurogenic trajectories of adult human, macaque, and pig hippocampal and entorhinal cells.
    https://medicine.yale.edu/
  5. VC Galvin, J Solder, F Luo, YM Morozov, et al. (2019). Noradrenergic α1-adrenoceptor actions in the primate dorsolateral prefrontal cortex.
    https://www.jneurosci.org/content/39/14/2722.abstract

Dr. Robert Barry Kerstein | Neuronal Cell Biology | Innovative Research Award

Published on by Cell Biologist

Dr. Robert Barry Kerstein | Neuronal Cell Biology | Innovative Research Award

North American Society of Digital Occlusion | United States

Robert B. Kerstein is a leading authority in computerized occlusal analysis, with extensive contributions to advancing digital bite measurement technologies. His research focuses on the development and clinical application of T-Scan systems, significantly improving diagnostic precision and treatment outcomes in dentistry. Through numerous peer-reviewed publications and edited research volumes, he has shaped modern understanding of occlusion and its role in oral health. His work promotes Digital Measured Occlusion, a systematic approach that enhances patient comfort, reduces prosthetic complications, and streamlines treatment efficiency, making it highly valuable in everyday dental practice and advanced prosthodontic care.

Citation Metrics (Scopus)

6000
4000
2000
200
100
50
0

Citations
1,865

Documents
61

h-index
25

Citations

Documents

h-index

Featured Publications

Abdelhamid Benazzouz | Neuronal Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Abdelhamid Benazzouz | Neuronal Cell Biology | Best Researcher Award

Bordeaux University / Neurodegenerative Diseases Institute | France

Dr. Abdelhamid Benazzouz is a distinguished neuroscientist whose pioneering research has significantly advanced understanding and treatment of Parkinson’s disease. His groundbreaking work during his Ph.D. led to the development of deep brain stimulation (DBS) of the subthalamic nucleus as a novel therapeutic approach for Parkinson’s disease, which was later translated into clinical application. His research focuses on elucidating the mechanisms of action of DBS, exploring the role of monoaminergic systems in the pathophysiology of Parkinson’s disease, and investigating pain mechanisms associated with the disorder. He has led numerous national and international research projects funded by organizations such as the Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, and the Michael J. Fox Foundation. With over 120 publications, more than 24,000 citations, and multiple patents, his contributions span both basic and translational neuroscience. He also leads collaborative research efforts across France, the Netherlands, and Hong Kong to develop innovative therapeutic strategies. As Editor-in-Chief and founder of the Elsevier journal Deep Brain Stimulation, he continues to influence the global neuroscience community, driving forward advancements in neurostimulation, monoaminergic signaling, and the treatment of neurological disorders, particularly Parkinson’s disease and related pain syndromes.

Profiles: Google Scholar | Orcid

Featured Publications:

Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., … & Benabid, A. L. (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. The New England Journal of Medicine, 349(20), 1925–1934.

Limousin, P., Krack, P., Pollak, P., Benazzouz, A. H., Ardouin, C., Hoffmann, D., … & Benabid, A. L. (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. The New England Journal of Medicine, 339(16), 1105–1111.

Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J. F., Perret, J. E., … & Benabid, A. L. (1995). Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. The Lancet, 345(8942), 91–95.

Benabid, A. L., Pollak, P., Gao, D., Hoffmann, D., Limousin, P., Gay, E., Payen, I., & Benazzouz, A. (1996). Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. Journal of Neurosurgery, 84(2), 203–214. Benazzouz, A., Gross, C., Féger, J., Boraud, T., & Bioulac, B. (1993). Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. European Journal of Neuroscience, 5(4), 382–389.

Krack, P., Pollak, P., Limousin, P., Hoffmann, D., Xie, J., Benazzouz, A., … & Benabid, A. L. (1998). Subthalamic nucleus or internal pallidal stimulation in young-onset Parkinson’s disease. Brain: A Journal of Neurology, 121(3), 451–457.

Benabid, A. L., Pollak, P., Gross, C., Hoffmann, D., Benazzouz, A., Gao, D. M., … & Perret, J. (1994). Acute and long-term effects of subthalamic nucleus stimulation in Parkinson’s disease. Stereotactic and Functional Neurosurgery, 62(1–4), 76–84.

Subodh Kumar | Neuronal Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Subodh Kumar | Neuronal Cell Biology | Best Researcher Award

Assist. Prof. Dr. Subodh Kumar | Texas Tech Univesrity Health Sciences Center El Paso | United States

Dr. Subodh Kumar is an Assistant Professor in Molecular and Translational Medicine at Texas Tech University Health Sciences Center (TTUHSC), El Paso. With a Ph.D. in Molecular Biology from PGIMER, India, and postdoctoral training in Neurobiology at TTUHSC, his work is rooted in understanding neurodegenerative diseases, especially Alzheimer’s disease (AD). He has significantly contributed to identifying synapse-localized microRNAs and their mechanistic roles in AD pathology. Dr. Kumar is the recipient of the prestigious NIH K99/R00 Career Development Award and the Marsh Foundation Research Award. His translational research spans biomarker discovery, synaptic dysfunction, and multi-omics analysis. As a corresponding author on several high-impact publications, Dr. Kumar has developed miRNA-based therapeutic strategies and diagnostics. He serves as an Associate Editor for the Journal of Alzheimer’s Disease and holds memberships in several professional neuroscience organizations. His ongoing research aims to translate molecular findings into innovative treatments for AD.

Publication Profile:

Scopus

✅ Strengths For The Award:

  1. Cutting-edge Research in Alzheimer’s Disease 🧠🧬: Dr. Kumar’s multi-omics and miRNA-focused studies provide novel insights into synaptic dysfunction in Alzheimer’s disease—an area with significant global impact and scientific relevance.

  2. High-impact Publications 📚: His work has appeared in top-tier journals such as Molecular Psychiatry, NPJ Genomic Medicine, Redox Biology, and Human Molecular Genetics—a testament to research quality and scientific contribution.

  3. Leadership & Innovation 🧪: He is the corresponding author on many publications, highlighting leadership in collaborative research. His pioneering discovery of miRNAs like miR-455-3p and miR-502-3p as biomarkers has translational potential.

  4. Consistent Funding & Recognition 💰🏆: Secured prestigious awards like the NIH K99/R00 and Marsh Foundation Research Award, showing trust and acknowledgment from the scientific community.

  5. Mentorship & Editorial Involvement ✏️: Active as an Associate Editor and likely mentoring younger researchers, showcasing academic service and leadership.

⚠️ Areas for Improvement:

  1. Global Collaboration 🌍: Though his current work is impactful, forming more global or cross-institutional collaborations could increase the international visibility of his research.

  2. Public Science Communication 📢: There’s little mention of science outreach or public education; engaging with broader audiences could amplify his societal impact.

  3. Commercialization & Patents: While one patent is listed, further steps toward translational research or biotech partnerships could accelerate clinical applications.

🎓 Education:

Dr. Kumar began his academic journey at CCS University, Meerut, India, where he earned a B.S. in Biology (2004) and an M.S. in Biotechnology (2005). He pursued his doctoral studies at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, where he earned his Ph.D. in Molecular Biology in 2014. His graduate research centered on liver-specific miRNAs in hepatitis C. He further expanded his expertise during a comprehensive postdoctoral training at Texas Tech University Health Sciences Center (TTUHSC), Lubbock, from 2015 to 2021, focusing on neurobiology and Alzheimer’s disease mechanisms. His advanced education combined molecular biology, genomics, and translational neuroscience, laying a solid foundation for his innovative contributions to AD research. Dr. Kumar’s academic training has uniquely equipped him to explore complex disease pathways, develop miRNA-based biomarkers, and use multi-omics approaches for therapeutic target discovery in neurodegeneration.

🧪 Experience:

Dr. Subodh Kumar has nearly two decades of research and academic experience spanning molecular biology, neuroscience, and translational medicine. Currently an Assistant Professor at TTUHSC El Paso (2022–Present), he previously served as a Research Assistant Professor and Postdoctoral Fellow at TTUHSC Lubbock (2015–2022). His early career included roles as a Senior and Junior Research Fellow at ICMR, India, and as a tutor in Biotechnology. He has mentored multiple students and leads independent NIH-funded research investigating microRNA roles in Alzheimer’s disease. Notably, his pioneering studies on synapse-localized miRNAs and multi-omics integration have shed light on novel targets and mechanisms underlying AD pathogenesis. He has also worked on liver-related miRNAs and their biomarker potential during hepatitis C virus infections. With a well-rounded profile combining teaching, laboratory research, and grant writing, Dr. Kumar’s experience reflects strong leadership in collaborative, interdisciplinary, and translational research.

🏅 Awards and Honors:

Dr. Kumar has received numerous accolades throughout his career, highlighting both his scientific excellence and research impact. Most notably, he was awarded the NIH NIA K99/R00 Pathway to Independence Award in 2020, supporting his pioneering work on microRNA in Alzheimer’s disease. In 2024, he received the Marsh Foundation Research Award at TTUHSC El Paso. His presentations and posters have been recognized at institutional and national levels, including the Best Oral Presentation Award at the 14th Annual Research Symposium (2022) and the Best Poster Award at the Healthy Aging and Dementia Symposium (2018). He has also received competitive fellowships and travel awards from prestigious Indian agencies such as CSIR and ICMR, including an International Travel Award and GATE fellowship. These honors reflect Dr. Kumar’s sustained excellence in translational neuroscience, innovation in biomarker discovery, and leadership in Alzheimer’s disease research.

🧬 Research Focus:

Dr. Subodh Kumar’s research focuses on the molecular mechanisms of synaptic dysfunction in Alzheimer’s disease (AD), with particular emphasis on synapse-localized microRNAs (miRNAs). His lab explores how deregulated miRNAs like miR-501-3p, miR-502-3p, and miR-455-3p affect synaptic protein expression, GABAergic function, and mitochondrial dynamics. Dr. Kumar integrates multi-omics approaches—including transcriptomics, proteomics, and miRNA sequencing—on human brain-derived synaptosomes to uncover novel biomarkers and therapeutic targets. His group also uses lentiviral vector systems and stereotaxic injections in mouse models to manipulate miRNA expression in vivo. These findings help clarify miRNA-mRNA-protein interactions in AD progression. Dr. Kumar also explores the diagnostic potential of miRNAs using patient-derived samples (CSF, serum, fibroblasts). His research bridges basic neuroscience with clinical translation, aiming to develop miRNA-based therapeutics and non-invasive diagnostic panels for early AD detection. His work holds promise in reshaping our understanding and treatment of neurodegenerative diseases.

📚 Publication Titles Top Notes:

  1. 🧠 Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer’s disease (Molecular Psychiatry, 2025)

  2. 🧬 MiRNA-501-3p and MiRNA-502-3p: a promising biomarker panel for Alzheimer’s disease (Clinical and Translational Medicine, 2025)

  3. 🧩 MicroRNA-502-3p Modulates the GABA A Subunits, Synaptic Proteins, and Mitochondrial Morphology in Hippocampal Neurons (Molecular Neurobiology, 2025)

  4. 🔬 MicroRNA-502-3p regulates GABAergic synapse function in hippocampal neurons (Neural Regeneration Research, 2024)

  5. 🧠 Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease (NPJ Genomic Medicine, 2022)

  6. 🧪 MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: relevance to Alzheimer’s disease (Redox Biology, 2021)

  7. 🧠 Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer’s disease (BBA, 2019)

  8. 🧬 MicroRNA-455-3p as a potential biomarker for Alzheimer’s disease: an update (Frontiers in Aging Neuroscience, 2018)

  9. 🧪 MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease (Human Molecular Genetics, 2017)

  10. 🧫 Crosstalk between microRNA-122 and FOX family genes in HepG2 cells (Exp Biology & Medicine, 2017)

📌 Conclusion:

Dr. Subodh Kumar is a highly suitable candidate for the Best Researcher Award. His research on microRNAs in neurodegeneration is groundbreaking, well-funded, and internationally recognized. With a robust publication record, academic leadership, and translational potential, he exemplifies the caliber expected of this distinction. Strategic enhancements in international outreach and translational ventures would further elevate his global impact.

Eunhee Lee | Neuronal Cell Biology | Best Research Article Award

Published on by Cell Biologist

Dr. Eunhee Lee | Neuronal Cell Biology | Best Research Article Award

Dr. Eunhee Lee, Daegu Gyeongbuk Medical Innovation Foundation, K-MEDI hub, South Korea

Dr. Eun-Hee Lee, Ph.D., is a distinguished biomedical researcher with expertise in therapeutic ultrasound and neurobiology. Currently serving as Senior Researcher and Head of the Advanced Technology Department at the Medical Device Development Center, DGMIF, South Korea, she has consistently contributed to the advancement of focused ultrasound applications in neurological disorders. With over a decade of research experience spanning government institutions and clinical collaborations, Dr. Lee has published extensively in peer-reviewed journals on brain delivery mechanisms, neuroinflammation, and neurodegeneration. Her pioneering studies have deepened our understanding of the blood-brain barrier and the therapeutic potential of ultrasound. Her work stands at the forefront of translational neuroscience, aiming to enhance drug delivery and brain repair mechanisms. Dr. Lee’s dedication to impactful and clinically relevant research makes her a strong contender for the Best Research Article Award.

Publication Profile: 

Scopus

✅ Strengths for the Award

  1. Innovative Research Focus:
    Dr. Lee’s work on focused ultrasound (FUS)-mediated blood-brain barrier (BBB) disruption is at the cutting edge of neurotherapeutics and non-invasive brain drug delivery. Her investigations hold promise for treating neurodegenerative disorders like Alzheimer’s disease and traumatic brain injuries.

  2. Extensive Peer-Reviewed Publications:
    With over 15 high-quality, peer-reviewed articles published from 2019 to 2024 in reputable journals like Scientific Reports, Frontiers in Neuroscience, and Biomedicines, her research output reflects consistent and impactful contributions.

  3. Interdisciplinary Approach:
    Her integration of biomedical engineering, imaging, and neurobiology enhances the translational value of her findings. Numerical modeling and simulation studies further strengthen the clinical feasibility of her techniques.

  4. Clinical and Preclinical Impact:
    Dr. Lee’s work bridges preclinical models (rats, skull simulations) with potential human applications, offering real translational pathways for drug delivery across the BBB.

  5. Leadership and Collaboration:
    As the Head of the Advanced Technology Department at DGMIF, she demonstrates leadership in medical innovation and fosters collaboration between academia, hospitals, and research institutes.

⚠️ Areas for Improvement

  1. Greater International Collaboration:
    While her work is deeply embedded in Korean institutions, expanding partnerships internationally could amplify her research reach and global influence.

  2. Clinical Trial Transition:
    Much of her published work is preclinical. Advancing to clinical trials or human pilot studies would significantly increase the translational impact of her findings.

  3. Public Engagement and Visibility:
    Enhanced visibility through global neuroscience or biomedical engineering conferences could further validate and showcase her research excellence.

🎓 Education:

Dr. Eun-Hee Lee received all her academic training from Chonnam National University, Kwangju, South Korea. She earned her Ph.D. (2007–2010) and M.S. (2005–2007) in Biological Sciences and Technology, gaining extensive knowledge in cellular and molecular biology. Her B.S. in Genetic Engineering (2001–2005) laid the groundwork for her interest in biomedical innovations and neurogenetics. During her graduate and doctoral studies, she focused on cellular pathways and gene expression relevant to neurodegenerative diseases and molecular interventions. Her academic journey shaped her multidisciplinary perspective, merging genetics, bioengineering, and neurobiology. These foundations have enabled her to pursue cutting-edge research on the blood-brain barrier, drug delivery systems, and brain stimulation. Dr. Lee’s strong academic background provides her with the theoretical and technical expertise essential for high-impact research.

🧪 Experience:

Dr. Eun-Hee Lee has more than 14 years of progressive research experience. Since 2017, she has led the Advanced Technology Department at DGMIF, where she develops novel medical devices using therapeutic ultrasound. Prior to this, she worked as a Research Scientist at the Korea Atomic Energy Institute’s Advanced Radiation Technology Institute (2015–2017), where she explored radiation-mediated biological responses. Between 2013 and 2015, she contributed to TB and molecular microbiology research at the Korean Institute of Tuberculosis. Her postdoctoral fellowship (2011–2012) at the NIH’s Division of HIV/AIDS and Tumor Viruses expanded her expertise into virology and immunopathology. Dr. Lee’s multidisciplinary roles across leading institutions demonstrate her adaptability, leadership, and commitment to translational science. Her professional trajectory shows strong contributions to national research priorities in healthcare and medical technology.

🔬 Research Focus:

Dr. Eun-Hee Lee’s research centers on focused ultrasound (FUS) as a non-invasive modality for drug delivery and neural repair. Her work explores ultrasound-mediated blood-brain barrier (BBB) disruption to enhance targeted therapeutic access to the brain. She also investigates ultrasound stimulation’s effects on neurogenesis, neuroinflammation, and neuroprotection in various neurological models including Alzheimer’s disease and spinal cord injury. Another significant area of focus includes numerical modeling of skull structures to improve the precision of transcranial FUS applications. Through collaborations with clinicians and physicists, Dr. Lee has produced evidence-based methodologies for safer, more effective BBB modulation. Her integrative approach, combining bioengineering, neuroimmunology, and computational simulation, is impactful in the field of therapeutic neuromodulation and has implications for treating neurodegenerative and cerebrovascular disorders.

📚 Publications Top Notes: 

  • 🧠 Numerical Investigation of Layered Homogeneous Skull Model for Simulations of Transcranial Focused Ultrasound (2024)

  • 🔥 The New Insight into the Inflammatory Response Following Focused Ultrasound-Mediated Blood-Brain Barrier Disruption (2022)

  • 🧪 Methylene Blue Delivery via Focused Ultrasound Reduces Neural Damage and Amyloid-Beta by AQP-4 Upregulation (2022)

  • 🐀 Novel Animal Model of Spontaneous Cerebral Petechial Hemorrhage Using Focused Ultrasound in Rats (2022)

  • ♻️ Ultrasound Stimulation Improves Inflammation Resolution and Functional Recovery After Spinal Cord Injury (2022)

  • 🚑 Relationship Between Treatment Types and BBB Disruption in Acute Ischemic Stroke: Two Case Reports (2022)

  • 🧲 Effects of Transducer Displacement on Focused Ultrasound in the Rat Brain (2022)

  • 📉 BBB Disruption After Syncope: A DCE-MRI Case Report (2021)

  • 🧪 Verification of BBB Disruption Using Rat Model with Human Skull (2021)

  • 💧 Localized Water Molecule Transport Modulation Post-FUS BBB Disruption (2021)

  • 🚨 DCE-MRI for Evaluating BBB Disruption in Traumatic Brain Injury: Review (2021)

  • 🧬 TREM2 Promotes Natural Killer Cell Development in pNK Cells (2021)

  • 🌿 Gintonin Enhances Donepezil Brain Delivery via LPA and VEGF Receptors (2021)

  • 🔄 Cyclophilin A is a Ligand for TREM2 in Myeloid Cells (2021)

  • 🧠 Local Differences in BBB Permeability Induced by Focused Ultrasound (2020)

  • 💉 Advanced FUS Protocol Improves Doxorubicin Delivery in Rat Brain (2019)

  • 🔄 FUS-Induced Diminished P-glycoprotein via JNK Pathway in Cerebral Vessels (2019)

🧾 Conclusion:

Dr. Eun-Hee Lee is a highly suitable candidate for the Best Research Article Award. Her work is scientifically rigorous, clinically relevant, and methodologically innovative. The focus on ultrasound-mediated drug delivery through the BBB is a transformative area in neuroscience and drug delivery technology. Her comprehensive research output, leadership, and translational potential strongly position her among top contenders for recognition. Encouraging clinical application and broader dissemination will only enhance the already substantial value of her contributions.